EuroDurg 2023: Scientific meeting with educational courses for researchers, policy makers from academia, healthcare professionals, PhD students and all who are interested in safe and
Many of ENABLE project members were present to 26th ESPACOMP Conference in Berlin (Germany), 17-19 November 2022. There were presented results of the activities during
Romanian ENABLE members and CASPA.RO (Community of Patient Associations from Romania) organized an online event entitled “Medication Adherence Day” on 15.11.2022.
Would you like to listen to Amanda’s experience with medication adherence? Watch the animation video! https://youtu.be/B6gCsinKURs
The event is provided by the COST Action 19132 ENABLE, Working Group 2. CA19132 ENABLE: “European Network to Advance Best practices & technology on medication
We would like to invite you to submit your medication adherence-related research to Research Topic propose fully created in Frontiers in Pharmacology (Impact Factor = 5.810). Recent
https://www.politicidesanatate.ro/non-aderenta-la-tratament-costa-uniunea-europeana-125-miliarde-euro/?utm_source=newsletter&utm_medium=email&utm_content=Newsletter-974333-20220630&utm_campaign=%23SubiecteleSaptamanii%3A+Finan%C8%9B%C4%83ri+Comisia+European%C4%83%2FCongres+EPF+2022%2F+Guvernan%C8%9Ba+HTA%2F
Dear ENABLE Working Group Members, We have the pleasure to invite you to the hybrid ENABLE Working Group Meeting in Oslo, Norway on June 24–25, 2022.
newsletter June 2022 1st Training School took place in Malaga From the 2nd to 4th of May the 1st training School from the ENABLE COST
This year’s ESPACOMP conference will have a special focus on Adherence and Patient Safety. The congress will be held in a hybrid format. Please submit your
Malaga Training School MALAGA Training School – Final Program (PDF doc) Working with Patients on Medication Adherence (MA), Practical Solutions Learning objectives: Raise awareness about
Prof. Przemysław Kardas will present about ENABLE “Availability of reimbursed interventions to advance medication adherence in Europe: recent findings of the ENABLE COST Action” at